---

Thomas Ryll

Vice President of Technical Operations, Immunogen

Thomas was highly commended by the judging panel for his dedication to industry and innovation, particularly in antibody drug conjugates. He has over 24 years of experience in bioprocessing, having worked for Genentech (where he was part of the first generation of large scale manufacturing processes for antibodies and recombinant proteins), Abgenix, Tanox, and Biogen, prior to Immunogen.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018